T46.6 - Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
The ICD 10 Code for
Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs is listed as
T46.6. Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.
| ICD 10 CM Field |
Value |
| Diagnosis Code: |
T46.6
|
| Description: |
Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs |
|
|
| Chapter |
Injury, poisoning and certain other consequences of external causes (S00-T88) |
| Block |
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50) |
| Parent |
T46 - Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system |
| ICD-10-CM Children (deeper level / typically more specific) of T46.6: |
|---|
| T46.6X - Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs |
| ICD-10-CM Siblings (same level / similar specificity) of T46.6: |
|---|
| T46.0 - Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action |
| T46.1 - Poisoning by, adverse effect of and underdosing of calcium-channel blockers |
| T46.2 - Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified |
| T46.3 - Poisoning by, adverse effect of and underdosing of coronary vasodilators |
| T46.4 - Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors |
| T46.5 - Poisoning by, adverse effect of and underdosing of other antihypertensive drugs |
| T46.7 - Poisoning by, adverse effect of and underdosing of peripheral vasodilators |
| T46.8 - Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents |
| T46.9 - Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system |
